Hepatitis C virus in long-term bone marrow transplant survivors

Bone Marrow Transplantation

Volumn 33, Issue 12, 2004, Pages 1181-1185

  Ivantes, C A P ^a   Amarante, H ^a,b   Ioshii, S O ^a   Pasquini, R ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b NONE   (Brazil)

Author keywords

Cirrhosis; Hepatitis C virus

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; HEPATITIS C ANTIBODY;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BONE MARROW TRANSPLANTATION; DISEASE COURSE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; BONE MARROW TRANSPLANTATION; DISEASE PROGRESSION; FEMALE; HEPACIVIRUS; HEPATITIS ANTIBODIES; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREVALENCE; SURVIVORS;

EID: 3242694354     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704519     Document Type: Article

References (27)

1. Choo QL, Kuo G, Weiner AJ et al. Isolation of a DNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-362.
2. Brazil. Ministry of Health. Administrative Rule no. 1376, of November 19, 1993. Diário Oficial, Brasilia, 1993; pp 18405-18415.
3. Strasser SI, McDonald GB. Gastrointestinal and hepatic complications. In: Thomas ED, Blume KG, Forman SJ (eds.). Hematopoietic Cell Transplantation. Blackwell Scientific Publications: Cambridge, 1999; pp 627-658.
4. Strasser SI, Myerson D, Spurgeon CL et al. Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up. Hepatology 1999; 29: 1893-1899.
5. Locasciulli A, Bacigalupo A, Vanlint MT et al. Hepatitis C virus infection and liver failure in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 16: 407-411.
6. Ljungman P, Johansson N, Aschan J et al. Long-term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients. Blood 1995; 86: 1614-1618.
7. Akiyama H, Yoshinaga H, Tanaka T et al. Effects of cyclosporin A on hepatitis C virus infection in bone marrow transplant patients. Bone Marrow Transplant 1997; 20: 993-995.
8. Poynard T. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825-832.
9. Stanton AG. Primer of Biostatistics: Version 4.0, 4 edn. McGraw Hill: New York, 1997.
10. Kolho E, Ruutu P, Ruutu T. Hepatitis C infection in BMT patients. Bone Marrow Transplant 1993; 11: 119-123.
11. Locasciulli A, Bacigalupo A, Vanlint MT et al. Hepatitis C virus infection in patients undergoing allogeneic bone marrow transplantation. Transplantation 1991; 52: 315-318.
12. Locasciulli A, Nava S, Sparano P, Testa M. Infections with hepatotropic viruses in children treated with allogeneic bone marrow transplantation. Bone Marrow Transplant 1998; 21 (Suppl.): 575-577.
13. Locasciulli A, Alberti A, de Bock R et al. Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European bone marrow transplantation group infectious diseases working party. Bone Marrow Transplant 1994; 14: 833-837.
14. Alter MJ, Kruszon-Moran D, Nainan OV et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556-562.
15. Silva AO et al. Dimensões epidêmicas da infecção causada pelo virus da hepatite C. (Epidemics of infection by hepatitis-C virus). In: Silva AO (ed.). Hepatite Viral C. Pizarro Farmacêutica: São Paulo, 2001; pp 27-35.
16. Heintges T, Wands JR. Hepatitis C virus: epidemiology and transmission. Hepatology 1997; 26: 521-526.
17. Cornu C, Brusselmans C, Geubel A et al. Anti-HCV seroconversion in multitransfused and Immunocompromised patients. Vox Sanguinis: Int J Blood Transf Immunohaematol 1994; 67: 286-290.
18. Tada K, Tajiri H, Kozaiwa K et al. Role of screening for hepatitis C virus in children with malignant disease and who undergo bone marrow transplantation. Transfusion 1997; 37: 641-644.
19. Lok AS, Chien D, Choo QL et al. Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosupressed patients. Hepatology 1993; 18: 497-502.
20. Locasciulli A, Testa M, Valsecchi MG et al. The role of hepatitis C and B virus infection as risk factors for severe liver complications following allogeneic BMT: a prospective study by the infectious disease working party of the European blood and marrow transplantation group. Transplantation 1999; 68: 1486-1491.
21. Strasser S, Sullivan KM, Myerson D et al. Cirrhosis of the liver in long-term marrow transplant survivors. Blood 1999; 93: 3259-3266.
22. Maruta A, Kanamori H, Fukawa H et al. Liver function texts of recipients with hepatitis virus infection after bone marrow transplantation. Bone Marrow Transplant 1994; 13: 417-422.
23. Tomas JF, Pinilla I, Gracia-Bucy ML et al. Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients. Bone Marrow Transplant 2000; 26: 649-655.
24. Norol F, Nadjahi J, Bachir D et al. Hepatitis C virus infection and allogeneic bone marrow transplantation. Transplantation 1994; 57: 393-397.
25. Mckay PJ, Murphy JA, Cameron S et al. Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation. Bone Marrow Transplant 1996; 17: 63-66.
26. Strasser S, McDonald G. Viruses and hematopoietic cell transplantation: a guide to patient and donor management. Blood 1999; 93: 1127-1136.
27. Ivantes CAP, Amarante H, Ioshii S, Pasquini R. Treatment of chronic hepatitis C in bone marrow transplant recipients. 2004; (submitted for publication).